The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
Perry, George
Plascencia Villa, German
Funded by
Univ of TX HSC at Houston 744
Alzheimer's disease (AD) is increasing in number as the U.S. and global population gets older. Despite enormous effort and expense. treatment remains at best modestly effective and no new drugs have been approved since 2003 [1.2]. The increasing interest in drug discovery through repositioning old drugs for new therapeutic applications throw light in the treatment for neurodegenerative diseases including AD [3].
Southwest Research Institute (SwRI), headquartered in San Antonio, Texas, is one of the oldest and largest independent, nonprofit, applied research and development (R&D) organizations in the United States.
Principal Investigator(s)
Dr. Jonathan Bohmann
Funded by
Medical CBRN Defense Consortium
Collaborating Institutions
University of Pittsburgh
Defense Threat Reduction Agency
Medical CBRN Defense Consortium
Southwest Research Institute has received funding from the Medical CBRN Defense Consortium (MCDC) administered by Advanced Technology International to develop a nerve agent antidote for emergency use on the battlefield or to protect public health.
Southwest Research Institute (SwRI), headquartered in San Antonio, Texas, is one of the oldest and largest independent, nonprofit, applied research and development (R&D) organizations in the United States.
Principal Investigator(s)
Dr. Joe McDonough
Funded by
San Antonio Partnership for Precision Therapeutics
Collaborating Institutions
The University of Texas at San Antonio
UT Health San Antonio
Texas Biomedical Research Institute
Leaders of the newly-established San Antonio Partnership for Precision Therapeutics (SA PPT) have awarded the partnership’s first research grant. A seven-person team researching sepsis-induced organ failure will receive $200,000 in funding over two years. The award’s purpose is to advance research and breakthroughs in precision therapeutics, which is the development of drug therapies for specific populations based on genetics, lifestyle and environment.
Southwest Research Institute (SwRI), headquartered in San Antonio, Texas, is one of the oldest and largest independent, nonprofit, applied research and development (R&D) organizations in the United States.
Collaborating Institutions
UT Health San Antonio)
Texas Biomedical Research Institute (Texas Biomed)
The University of Texas at San Antonio (UTSA)
Presidents of San Antonio’s four largest research institutions today announced they are providing $800,000, collectively, for a major initiative in precision therapeutics. The process of precision therapeutics ultimately leads to breakthrough treatments that can be individualized to specific patient populations.
The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.
Principal Investigator(s)
Chen, Chu
Funded by
NIH-NATIONAL INSTITUTE ON AGING
Alzheimer's disease (AD) is the most common cause of dementia in the elderly and a majority of AD cases issporadic without known causes. While the etiology of AD is multifactorial and complex, growing evidencesuggests that traumatic brain injury (TBI) is a risk factor for development of AD and dementia. Repetitive TBIcauses chronic traumatic encephalopathy (CTE), a progressive neurodegenerative disease. Pathological TDP-43 inclusions are one of the important hallmarks of neuropathology in CTE.
The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.
Principal Investigator(s)
Hiroi, Noboru
Funded by
NIH-NATL INSTITUTE OF MENTAL HEALTH
Cognitive deficits are major disabling impairments associated with autism and schizophrenia. Because theunderlying genetic and cellular mechanisms of such deficits are still poorly understood, mechanism-basedtherapeutic options do not exist, limiting the effective integration of patients into society. Previous clinical workhas shown that executive functions such as working memory and cognitive flexibility start to lag behind fromadolescence to adulthood in individuals with autism and schizophrenia.